New Technologies

United Research Institute of SINOVAC serves as the innovation source and drug discovery engine for SINOVAC, committed to "Connecting the power of global science and promoting global health". Focusing on clinical needs in major global disease areas, it integrates cutting-edge basic scientific research and significant achievements, concentrating superior forces to develop first-in-class innovative biologics such as vaccines, antibodies, and fusion proteins, aiming for rapid market entry of high-value products.

Leveraging SINOVAC’s R&D platform, United Research Institute of SINOVAC plans to establish a "high-precision, cutting-edge biopharmaceutical frontier results transformation base" in Changping District, Beijing, adjacent to the Life Science Park. With a total construction area of 120,000 square meters, it will be operational by 2024. The projects and innovative pharmaceutical products from the United Research Institute of SINOVAC and research institutions will be implemented here. Creating a global frontier R&D platform and adopting a "self-use + collaboration" operation model, this base will connect with cutting-edge biopharmaceutical achievements, providing R&D, pilot testing, and industrialization platform support to accelerate transformations.